208 related articles for article (PubMed ID: 32271760)
21. The knock-down of ERCC1 but not of XPF causes multinucleation.
Rageul J; Frëmin C; Ezan F; Baffet G; Langouët S
DNA Repair (Amst); 2011 Sep; 10(9):978-90. PubMed ID: 21839691
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of the ERCC1-XPF structure-specific endonuclease to overcome cancer chemoresistance.
McNeil EM; Astell KR; Ritchie AM; Shave S; Houston DR; Bakrania P; Jones HM; Khurana P; Wallace C; Chapman T; Wear MA; Walkinshaw MD; Saxty B; Melton DW
DNA Repair (Amst); 2015 Jul; 31():19-28. PubMed ID: 25956741
[TBL] [Abstract][Full Text] [Related]
23. Reduced hematopoietic reserves in DNA interstrand crosslink repair-deficient Ercc1-/- mice.
Prasher JM; Lalai AS; Heijmans-Antonissen C; Ploemacher RE; Hoeijmakers JH; Touw IP; Niedernhofer LJ
EMBO J; 2005 Feb; 24(4):861-71. PubMed ID: 15692571
[TBL] [Abstract][Full Text] [Related]
24. Computer-aided drug design of small molecule inhibitors of the ERCC1-XPF protein-protein interaction.
Gentile F; Elmenoufy AH; Ciniero G; Jay D; Karimi-Busheri F; Barakat KH; Weinfeld M; West FG; Tuszynski JA
Chem Biol Drug Des; 2020 Apr; 95(4):460-471. PubMed ID: 31891209
[TBL] [Abstract][Full Text] [Related]
25. Activity of individual ERCC1 and XPF subunits in DNA nucleotide excision repair.
Gaillard PHL; Wood RD
Nucleic Acids Res; 2001 Feb; 29(4):872-9. PubMed ID: 11160918
[TBL] [Abstract][Full Text] [Related]
26. The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks.
Niedernhofer LJ; Odijk H; Budzowska M; van Drunen E; Maas A; Theil AF; de Wit J; Jaspers NG; Beverloo HB; Hoeijmakers JH; Kanaar R
Mol Cell Biol; 2004 Jul; 24(13):5776-87. PubMed ID: 15199134
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells.
Arora S; Kothandapani A; Tillison K; Kalman-Maltese V; Patrick SM
DNA Repair (Amst); 2010 Jul; 9(7):745-53. PubMed ID: 20418188
[TBL] [Abstract][Full Text] [Related]
28. Physiological consequences of defects in ERCC1-XPF DNA repair endonuclease.
Gregg SQ; Robinson AR; Niedernhofer LJ
DNA Repair (Amst); 2011 Jul; 10(7):781-91. PubMed ID: 21612988
[TBL] [Abstract][Full Text] [Related]
29. Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression.
Usanova S; Piée-Staffa A; Sied U; Thomale J; Schneider A; Kaina B; Köberle B
Mol Cancer; 2010 Sep; 9():248. PubMed ID: 20846399
[TBL] [Abstract][Full Text] [Related]
30. Repair synthesis step involving ERCC1-XPF participates in DNA repair of the Top1-DNA damage complex.
Takahata C; Masuda Y; Takedachi A; Tanaka K; Iwai S; Kuraoka I
Carcinogenesis; 2015 Aug; 36(8):841-51. PubMed ID: 26025908
[TBL] [Abstract][Full Text] [Related]
31. DNA repair endonuclease ERCC1-XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy.
McNeil EM; Melton DW
Nucleic Acids Res; 2012 Nov; 40(20):9990-10004. PubMed ID: 22941649
[TBL] [Abstract][Full Text] [Related]
32. First reported patient with human ERCC1 deficiency has cerebro-oculo-facio-skeletal syndrome with a mild defect in nucleotide excision repair and severe developmental failure.
Jaspers NG; Raams A; Silengo MC; Wijgers N; Niedernhofer LJ; Robinson AR; Giglia-Mari G; Hoogstraten D; Kleijer WJ; Hoeijmakers JH; Vermeulen W
Am J Hum Genet; 2007 Mar; 80(3):457-66. PubMed ID: 17273966
[TBL] [Abstract][Full Text] [Related]
33. The Fanconi anemia protein, FANCG, binds to the ERCC1-XPF endonuclease via its tetratricopeptide repeats and the central domain of ERCC1.
Wang C; Lambert MW
Biochemistry; 2010 Jul; 49(26):5560-9. PubMed ID: 20518486
[TBL] [Abstract][Full Text] [Related]
34. Defective transcription initiation causes postnatal growth failure in a mouse model of nucleotide excision repair (NER) progeria.
Kamileri I; Karakasilioti I; Sideri A; Kosteas T; Tatarakis A; Talianidis I; Garinis GA
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2995-3000. PubMed ID: 22323595
[TBL] [Abstract][Full Text] [Related]
35. RPA activates the XPF-ERCC1 endonuclease to initiate processing of DNA interstrand crosslinks.
Abdullah UB; McGouran JF; Brolih S; Ptchelkine D; El-Sagheer AH; Brown T; McHugh PJ
EMBO J; 2017 Jul; 36(14):2047-2060. PubMed ID: 28607004
[TBL] [Abstract][Full Text] [Related]
36. The Cerebro-oculo-facio-skeletal Syndrome Point Mutation F231L in the ERCC1 DNA Repair Protein Causes Dissociation of the ERCC1-XPF Complex.
Faridounnia M; Wienk H; Kovačič L; Folkers GE; Jaspers NG; Kaptein R; Hoeijmakers JH; Boelens R
J Biol Chem; 2015 Aug; 290(33):20541-55. PubMed ID: 26085086
[TBL] [Abstract][Full Text] [Related]
37. DNA structural elements required for ERCC1-XPF endonuclease activity.
de Laat WL; Appeldoorn E; Jaspers NG; Hoeijmakers JH
J Biol Chem; 1998 Apr; 273(14):7835-42. PubMed ID: 9525876
[TBL] [Abstract][Full Text] [Related]
38. TGF beta promotes repair of bulky DNA damage through increased ERCC1/XPF and ERCC1/XPA interaction.
Zheng H; Jarvis IWH; Bottai M; Dreij K; Stenius U
Carcinogenesis; 2019 Jun; 40(4):580-591. PubMed ID: 30418489
[TBL] [Abstract][Full Text] [Related]
39. Mapping of interaction domains between human repair proteins ERCC1 and XPF.
de Laat WL; Sijbers AM; Odijk H; Jaspers NG; Hoeijmakers JH
Nucleic Acids Res; 1998 Sep; 26(18):4146-52. PubMed ID: 9722633
[TBL] [Abstract][Full Text] [Related]
40. Repair protein persistence at DNA lesions characterizes XPF defect with Cockayne syndrome features.
Sabatella M; Theil AF; Ribeiro-Silva C; Slyskova J; Thijssen K; Voskamp C; Lans H; Vermeulen W
Nucleic Acids Res; 2018 Oct; 46(18):9563-9577. PubMed ID: 30165384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]